View all cases
- Case details
- StatusWithdrawnActionProcedural applicationCategoryOther procedural
- Parties
- Respondents
- Dexcom Inc.Operating co.
- Dexcom International LimitedOperating co.
Representatives- Tjibbe Douma-Bird & Bird LLP
- Division
- The Hague LD
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Jan 29, 2025
- EPO Opposition
- Dexcom, Inc.Withdrawn2024-03-14
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| The Hague LD | Locked |
| Judge Edger Brinkman | Locked |
At the UPC: Abbott Group (67 cases)·Dexcom Group (39 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
CC 20188/2024·CC 13509/2024·UPC CFI 425/2023·UPC CFI 424/2023·UPC APP 36267/2024 and 4 more
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2024
Decisions
- 2025-01-29
Summary: The Hague Local Division order allowing withdrawal of all claims and counterclaims in infringement proceedings between Abbott Diabetes Care Inc. and Dexcom Inc. concerning EP 4 070 727. All parties requested withdrawal; the court allowed the withdrawals and ordered reimbursement of 20% of court fees to the defendant/counterclaimant Dexcom per R. 370.9. The proceedings are closed.
Show the legal issues (3)
- Withdrawal of infringement action and counterclaims for revocation (R. 265 RoP)
- Reimbursement of court fees (R. 370.9 RoP)
- Continuous glucose monitoring device patents
Documents
- A559051A02CAC7ABAB2B4204EEF3864F_en.pdf2025-01-29EN